Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands ; volume:3 ; number:5 ; year:2014 ; pages:206-218 ; extent:13
ChemistryOpen ; 3, Heft 5 (2014), 206-218 (gesamt 13)

Creator: Schaab, Carolin
Kling, Ralf Christian
Einsiedel, Jürgen
Hübner, Harald
Clark, Timothy
Seebach, Dieter
Gmeiner, Peter

DOI: 10.1002/open.201402031

URN: urn:nbn:de:101:1-2023011506361529669161

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Schaab, Carolin
Kling, Ralf Christian
Einsiedel, Jürgen
Hübner, Harald
Clark, Timothy
Seebach, Dieter
Gmeiner, Peter

Other Objects (12)

Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor

Structure-Based Development of Selective Orexin 1 Receptor Antagonists

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands

Evolutionary design of selective adenosine receptor ligands

Hochschulschrift

Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation

Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography

Hochschulschrift

Drug design studies on selective dopamine receptor ligands

Opioid receptor oligomerization study through fluorescent selective ligands

Hochschulschrift

Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands

Hochschulschrift

Development of potent and selective dopamine D3 receptor ligands

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Hochschulschrift

Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators

Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor

Structure-Based Development of Selective Orexin 1 Receptor Antagonists

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands

Evolutionary design of selective adenosine receptor ligands

Hochschulschrift

Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation

Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography

Hochschulschrift

Drug design studies on selective dopamine receptor ligands

Opioid receptor oligomerization study through fluorescent selective ligands

Hochschulschrift

Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands

Hochschulschrift

Development of potent and selective dopamine D3 receptor ligands

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Hochschulschrift

Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators

Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor

Structure-Based Development of Selective Orexin 1 Receptor Antagonists

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands

Evolutionary design of selective adenosine receptor ligands

Hochschulschrift

Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation

Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography

Hochschulschrift

Drug design studies on selective dopamine receptor ligands

Opioid receptor oligomerization study through fluorescent selective ligands

Hochschulschrift

Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands

Hochschulschrift

Development of potent and selective dopamine D3 receptor ligands

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Hochschulschrift

Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor

Structure-Based Development of Selective Orexin 1 Receptor Antagonists

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands

Evolutionary design of selective adenosine receptor ligands

Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation

Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography

Drug design studies on selective dopamine receptor ligands

Opioid receptor oligomerization study through fluorescent selective ligands

Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands

Development of potent and selective dopamine D3 receptor ligands

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators

Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor

Structure-Based Development of Selective Orexin 1 Receptor Antagonists

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands

Evolutionary design of selective adenosine receptor ligands

Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation

Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography

Drug design studies on selective dopamine receptor ligands

Opioid receptor oligomerization study through fluorescent selective ligands

Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands

Development of potent and selective dopamine D3 receptor ligands

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators

Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor

Structure-Based Development of Selective Orexin 1 Receptor Antagonists

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands

Evolutionary design of selective adenosine receptor ligands

Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation

Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography

Drug design studies on selective dopamine receptor ligands

Opioid receptor oligomerization study through fluorescent selective ligands

Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands

Development of potent and selective dopamine D3 receptor ligands

Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators

Related objects

Reset password